3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Spinal Cord Neoplasms
1
Neurofibrosarcoma
1
Neurofibroma
1
Nerve Sheath Neoplasms
1
Interventions
Doxorubicin
6
Radiotherapy
5
selinexor
4
pazopanib
3
Sirolimus
3
Ifosfamide
3
AZD 6244
3
pembrolizumab
2
fludarabine phosphate
2
Radiation Dose Hypofractionation
2
Nivolumab
2
Etoposide
2
thymoglobulin
1
temsirolimus
1
tazemetostat
1
sotigalimab
1
ribociclib
1
pexidartinib
1
pegfilgrastim
1
liposomal doxorubicin
1
lentiviral minigene vaccine of COVID-19 coronavirus
1
ixazomib
1
fludarabine
1
decitabine and cedazuridine drug combination
1
X-Rays
1
Thiotepa
1
Tacrolimus
1
Surgical Procedures, Operative
1
Sunitinib
1
Stem Cell Transplantation
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neurofibrosarcoma
×
Neurofibromin 1
×
Clear all
NCT01567787
2017-02-10
NF01
University of Florida
Phase NA
Withdrawn